Cognoa Seeks De Novo Clearance For AI-Powered Diagnostic App For Autism After Successful Study

FDA clearance of the ASD Diagnostic app could lead to early diagnosis, improving quality of life of children with ASD and their caregivers. 

A colorful autism awareness puzzle background with wood texture illustration.

Cognoa is one step closer in its effort to get the first US Food and Drug Administration-cleared medical device for early diagnosis of autistic spectrum disorder (ASD) to market.

The Palo Alto, CA-based company announced on 23 September it will be submitting its artificial-intelligence-powered digital app for early detection...

More from Diagnostics

More from Device Area